Article
Molecular analysis of acute intermittent porphyria: mutation screening in 20 patients in Germany reveals 11 novel mutations.
Blood cells, molecules & diseases - 1 Jan 2000
von Brasch Léon, Zang Chuanbing, Haverkamp Thomas, Schlechte Horst, Heckers Herbert, Petrides Petro E
Abstract excerpt
Acute intermittent porphyria (AIP) is a very rare autosomal dominant disorder with low penetrance. Mutations in the gene of the porphobilinogen deaminase (PBG-D), also called hydroxymethylbilane synthase (HMBS), cause a partial deficiency of this enzyme of the heme biosynthetic pathway. Overstimulation of heme biosynthesis causes clinical symptoms. Because of the variability of the symptoms, diagnosis is often...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
